The lion at crossroads
India's over dependence on China for supply of APIs and bulk drugs is a serious threat to ‘Make in India’. PSUs could be the key…
Author
Promise & Power of Probiotics
September 20, 2017 | Trident, BKC, Mumbai
Express Pharma invites you for a select roundtable discussion to discuss more about the…
IDMA presents action plan for APIs to CDSCO
It also covered issues of APIs production, constraints faced by industry and guidelines to tackle emergency situations
Indian…
Our key approach is to focus on quality
Chris Henshall, Senior Director, Strategic Marketing – Biologics, West Pharmaceutical Services, in an interaction with Usha…
We are currently working with almost all major pharma companies in Asia Pacific
Sylvia Hii, Founder & VP – Marketing, Digital A Plus Group of Companies in an interaction with Usha Sharma, elaborates on the…
We are collaborating with pharma companies worldwide to adopt eco-friendly methods
Over the years, Ideal Cures’ R&D department has helped pharma companies to adopt eco-friendly methods and increase…
Clariant announced its financial results for the year ended March 31, 2017
Net Sales for the 12 months ended March 2017 grew by 7.9 per cent, the Board recommends a final dividend of Rs 25/- per share
Sun Pharma received US FDA acceptance of BLA for Tildrakizumab
Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis
Novartis India announces results for the quarter and year ended March 31, 2017
During FY 2016-2017 total income stood at ₹ 726.4 crore in comparison to ₹ 770.8 crore recorded in the previous corresponding…
GNH imports Olaratumab to India
It is a monoclonal antibody developed for the treatment of solid tumours soft tissue sarcomas
GNH India, pharmaceutical…